Clinical trial
Minimally Invasive Surgical Therapy for BPH
NCT00064649 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00064649 |
|---|---|
| Title | Minimally Invasive Surgical Therapy for BPH |
| Official title | Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia |
| Acronym | MIST |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Diagnostic Ultrasound Industry Urologix Medtronic Merck Sharp & Dohme LLC Sanofi-Synthelabo |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Benign Prostatic Hyperplasia |
| Intervention type | Device, Drug |
| Interventions | Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA) Therapy, Finasteride and Alfuzosin |
| Enrollment | 49 |
| Start date | Apr 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Jul 11, 2003 |
| Last update posted | Jan 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: